Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-01-06 @ 12:03 PM
Study NCT ID:
NCT06846567
Status:
COMPLETED
Last Update Posted:
2025-02-27
First Post:
2025-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of BM2216 ER vs. Melogabalin Besilate: Safety, PK, and Food Effect in Healthy Adults
Sponsor:
Zhejiang Anglikang Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-12
Completion Date Type:
ACTUAL
First Submit Date:
2025-02-17
First Submit QC Date:
None
Study First Post Date:
2025-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-25
Last Update Post Date:
2025-02-27
Last Update Post Date Type:
ACTUAL